Expanding Manufacturing Capacity Althea has recently expanded its facilities in San Diego, including a state-of-the-art 57,000-square-foot pharmaceutical manufacturing plant, indicating strong growth and increasing demand for their contract development and manufacturing services.

Focus on High Potency Drugs The company has developed a specialized GMP high potency products (HPP) manufacturing suite, highlighting expertise and equipment tailored for clients requiring safety and precision in potent drug manufacturing, which presents opportunities to target biotech firms with specialized needs.

Strong Financial Position With annual revenues estimated between $100 million and $250 million, Althea demonstrates solid financial health, making it a reliable partner for collaboration and long-term projects in the biotech manufacturing sector.

Industry Specialization Althea's focus on aseptic fill finish and drug formulation positions it as a key manufacturer for biotech and pharmaceutical companies seeking high-quality, process-driven manufacturing solutions to accelerate their product timelines.

Technological Capabilities Utilizing modern web technologies and a comprehensive approach to process development, Althea shows significant investment in quality and operational excellence, which can appeal to clients seeking innovative, reliable manufacturing partners.